Shanghai Bovax Biotechnology Co., Ltd.

Overview

Shanghai Bovax Biotechnology Co., Ltd., headquartered in Shanghai, China, specializes in the research, development, and commercialization of innovative biopharmaceutical products. The company is committed to advancing biotechnology solutions to address unmet medical needs.

Therapeutic areas

API / Drug Master Files

Shanghai Bovax Biotechnology Co., Ltd. holds 42 active (42 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RNASE R GMP-GRADE (20 U/UL)Active2026-03-31
• HUMAN ADIPOSE MESENCHYMAL STEM CELLS-DERIVED EXTRACELLULAR VESICLESActive2025-12-28
• RECOMBINANT HUMAN IL-3 GMP PROTEINActive2025-09-29
• N4-AC-DMT-2'-O-TBDMS-CR-AMIDITEActive2025-08-15
• ULTRAAAV TRANSFECTION REAGENT-GMPActive2025-06-30
• HUMAN UMBILICAL WHARTON'S JELLY MESENCHYMAL STEM CELL EXOSOMESActive2025-06-28
• T7 RNA POLYMERASE GMP-GRADRE (LOW DSDNA)Active2025-06-23
• DMT-2'-F-G(IBU)-CE-PHOSPHORAMIDITEActive2025-05-26
• POLYDEOXYRIBONUCLEOTIDES (PDRN) (SODIUM DNA)Active2025-03-16
• IMMOBILIZED METAL ION AFFINITY CHROMATOGRAPHYActive2025-03-11
• PROTEIN A AFFINITY CHROMATOGRAPHYActive2025-01-23
• HIFTRA™ PEI GMP TRANSFECTION REAGENTActive2024-12-20
• DMT-2'-F-DC(AC) PHOSPHORAMIDITEActive2024-10-29
• DMT-2'-OME-RG(IBU)-CE-PHOSPHORAMIDITEActive2024-10-13
• DMT-2'-OME-RC(AC)-CE-PHOSPHORAMIDITEActive2024-09-24

Showing 15 of 42 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Shanghai Bovax Biotechnology Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.